Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

Wanebo HJ, Lee J, Burtness BA, Ridge JA, Ghebremichael M, Spencer SA, Psyrri D, Pectasides E, Rimm D, Rosen FR, Hancock MR, Tolba KA, Forastiere AA.

Ann Oncol. 2014 Oct;25(10):2036-41. doi: 10.1093/annonc/mdu248. Epub 2014 Jul 9.

2.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
3.

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.

Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Jovanovic B, Vokes EE.

Clin Cancer Res. 2004 Mar 15;10(6):1956-62.

4.

Severe dermatologic reactions at multiple sites after paclitaxel administration.

Beri R, Rosen FR, Pacini MJ, Desai SR.

Ann Pharmacother. 2004 Feb;38(2):238-41. Epub 2003 Dec 19.

PMID:
14742758
5.

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5936-43.

6.

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.

Rosen FR, Haraf DJ, Kies MS, Stenson K, Portugal L, List MA, Brockstein BE, Mittal BB, Rademaker AW, Witt ME, Pelzer H, Weichselbaum RR, Vokes EE.

Clin Cancer Res. 2003 May;9(5):1689-97.

7.

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ.

J Clin Oncol. 2003 Jan 15;21(2):320-6.

PMID:
12525525
8.

Inactivation of endotoxin by a humoral component. V. EDC activity during gramnegative infection and shock.

ROSEN FR, LANDY M.

Z Immun exp ther. 1959 Oct-Nov;118:262-8. No abstract available.

PMID:
14438876

Supplemental Content

Loading ...
Support Center